Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zyversa Therapeutics Inc (ZVSA)

Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zyversa Therapeutics Inc 2200 N. COMMERCE PARKWAY SUITE 208 WESTON FL 33326 USA

www.zyversa.com Employees: 7 P: 754231688

Description:

ZyVersa Therapeutics Inc. is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates which address high unmet medical needs in the areas of renal and inflammatory diseases. The company's development pipeline includes phase 2a ready VAR 200 and IC 100. ZyVersa Therapeutics Inc., formerly known as Larkspur Health Acquisition Corp., is based in WESTON, Fla.

Key Statistics

Overview:

Market Capitalization, $K 2,649
Enterprise Value, $K -491
Shares Outstanding, K 2,344
Annual Sales, $ 0 K
Annual Net Income, $ -98,300 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,400 K
EBIT, $ -21,780 K
EBITDA, $ -9,870 K
60-Month Beta 0.65
% of Insider Shareholders 0.59%
% of Institutional Shareholders 3.91%
Float, K 2,330
% Float 99.41%
Short Volume Ratio 0.46

Growth:

1-Year Return -96.15%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.43 on 11/14/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -10.27
EPS Growth vs. Prev Qtr 26.59%
EPS Growth vs. Prev Year 92.28%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 04/26/24

ZVSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -224.85%
Return-on-Assets % -103.22%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.17
Book Value/Share 6.83
Interest Coverage -8.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar